Dr H.M.H. Spronk, Ph.D.

Bondi, E., Obino, G., Guidotti, G., Sensini, A., Nagy, M., Spronk, H. M. H., van Griensven, M., Lepedda, A. J., Lotti, N., & Moroni, L. (2026). Aromatic Copolyesters Based on Poly(butylene furanoate) and Poly(butylene isophthalate) for Small-Diameter Vascular Applications. ACS Biomaterial Science and Engineering. Advance online publication. https://doi.org/10.1021/acsbiomaterials.6c00106

Schellens, J., Nagy, M., Hulshof, A. M., van Rosmalen, F., van Oerle, R., van Herpt, T. T. W., Alnima, T., Mulder, M. M. G., Hellenbrand, D., ten Cate, H., Driessen, R. G. H., Sels, J. W. E. M., van der Horst, I. C. C., Henskens, Y. M. C., van Bussel, B. C. T., Spronk, H. M. H., & Dutch Covid and Thrombosis Coalition (2026). Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort. Thrombosis Research, 262, Article 109723. https://doi.org/10.1016/j.thromres.2026.109723

Urlings, E. H., Heubel-Moenen, F. C. J. I., van Oerle, R., Hellenbrand, D. L. S., van der Meijden, P. E. J., Hackeng, T. M., Cate, H. T., Nagy, M., Henskens, Y. M. C., & Spronk, H. M. H. (2026). Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A. Research and practice in thrombosis and haemostasis, 10(4), Article 106627. https://doi.org/10.1016/j.rpth.2026.106627

Franssen, I. S., Jong, M. J. D., Vievermans, A., Stroo, J. F., Henskens, Y. M. C., Spronk, H., Janssen, D. J. A., Braeken, D., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). Adequacy of Direct Oral Anticoagulant Dosing in Nursing Home Residents: Cross-Sectional Data From the DOAC-FRAIL Study. Journal of the American Medical Directors Association, 27(4), Article 106082. https://doi.org/10.1016/j.jamda.2025.106082

Nagy, M., Gomes, T., Van Oerle, R., Hacking, T. M., Magdelijns, F. J. H., Henskens, Y. M. C., Reitsma, P., Short, G., Spronk, H. M. H., & Verhoef, D. (2026). Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001. Research and practice in thrombosis and haemostasis, 10(2), Article e103375. https://doi.org/10.1016/j.rpth.2026.103375

D'alessandro, E., Scaf, B., Opacic, D., van Hunnik, A., Sobota, V., Kuiper, M., Viola, M., Hutschalik, T., Langione, M., Pioner, J. M., Munts, C., Simons, J., Winters, J., Isaacs, A., Heitmeier, S., Stoll, M., van Oerle, R., Ten Cate, H., Spronk, H. M. H., ... Schotten, U. (2026). Rivaroxaban Treatment Prevents Atrial Myocyte Hypertrophy in Goats with Persistent Atrial Fibrillation by Inhibition of Protease-Activated Receptor-1. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2761-6106

Obino, G., Nieddu, G., Nagy, M., Ippel, H., Cubeddu, T., Spronk, H. M. H., Hackeng, T. M., Formato, M., Lepedda, A. J., & Moroni, L. (2025). Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications. Cell Biomaterials, 1(10), Article 100155. https://doi.org/10.1016/j.celbio.2025.100155

van der Bie, J., Coleon, A., Visser, D., Bogers, W. M., den Dunnen, J., Spronk, H. M. H., Langermans, J. A. M., Willemen, H. L. D. M., De Melo, G. D., Middeldorp, J., & Stammes, M. A. (2025). Post Pandemic Problem, is there an animal model suitable to investigate PASC. npj Imaging, 3(1), Article 41. https://doi.org/10.1038/s44303-025-00101-2

Wang, M., Taha, A., Nagy, M., Raben, J. D., van Noort, R., Volovici, V., Dammers, R., Duncker, D. J., Spronk, H., Ten Cate, H., Dippel, D., Bobi, J., & van Beusekom, H. M. M. (2025). Microvascular Occlusion and Postrecanalization Hyperperfusion in a Swine Model of Acute Ischemic Stroke. Journal of the American Heart Association, 14(18), Article e042663. https://doi.org/10.1161/JAHA.125.042663

Baaten, C. C. F. M. J., Wollenhaupt, J., Henning, T. M., Vondenhoff, S., Schröer, J. R., Stamellou, E., Saritas, T., Kurt, B., Boger, L., Antwerpen, A., Hermann, J., Nagy, M., Sternkopf, M., Buhl, E. M., Raffetseder, U., van der Meijden, P. E. J., Kuijpers, M. J. E., Spronk, H. M. H., Schunk, S. J., ... Noels, H. (2025). Impaired Secondary Platelet Response in Chronic Kidney Disease as a Consequence of Prior Platelet Activation. JACC: Basic to Translational Science, 10(9), Article 101355. https://doi.org/10.1016/j.jacbts.2025.101355